|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Fasting serum lipids and serum lipoprotein distribution during oral |
| contraceptive therapy in Nigerians. |
| Journal of Obstetrics and Gynaecology of the British Commonwealth 80(8): 750- |
| Since several studies have reported elevated fasting serum triglyceride and cholesterol levels in Caucasian women |
| using oral contraceptives, serum lipids and lipoproteins were measured in Nigerian women prescribed oral |
| contraceptives at the Lagos University Teaching Hospital. 100 women, age 21-39, had been on oral contraceptive |
| therapy for 3-100 weeks; 39 had been taking Ovral (norgestrol, .5 mg and ethinyl estradiol, .05 mg) and 61 had been |
| taking Orthonovin (norethisterone, 1 mg and mestranol, .05 mg). 40 controls were of comparable age and weight but |
| had never used oral contraceptives. Venous blood samples were obtained after an overnight fast of at least 12 |
| hours. Significant increases in mean level were observed in the oral contraceptors for serum cholesterol (p less than |
| .01), cholesterol esters (p less than .01), and triglycerides (p less than .001). No difference was seen between the |
| mean serum cholesterol levels of the 2 oral-contraceptive groups. No significant correlation was seen between the |
| level of serum triglyceride and the duration of therapy, age, or weight. 10 patients using oral contraceptives |
| developed massive hyperlipemia. In the contraceptors a tendency, exaggerated in the hyperlipemia cases, for the |
| lipoprotein distribution to involve increased percentages of beta- and prebeta-lipoproteins and a decreased |
| percentage of alpha-lipoproteins existed. (PubHealth.info Document ID: CONT8T 86-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Fasting serum lipids and serum lipoprotein distribution |
| during oral contraceptive therapy in Nigerians.", is(are) Kuku SB; Akinyanju PA. The source of this article is |
| "Journal of Obstetrics and Gynaecology of the British Commonwealth 80(8): 750-753. August 1973.". This article was |
| published in 1973 in English language(s). (PubHealth.info® Document ID: CONT8T 86-06. All rights reserved with |
| PubHealth.info) PIN: 35086 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |